Literature DB >> 17868879

Blockade of integrin beta3-FAK signaling pathway activated by osteopontin inhibits neointimal formation after balloon injury.

Mei Han1, Jin-Kun Wen, Bin Zheng, Zhimin Liu, Yunhui Chen.   

Abstract

BACKGROUND: Osteopontin (OPN) promotes the migration and adhesion of vascular smooth muscle cells (VSMCs) through cell surface receptor, integrin beta3. In order to elucidate the signaling pathway by which OPN is involved in neointimal formation, we focused on integrin beta3-focal adhesion kinase (FAK) upon VSMC migration.
METHODS: The integrin beta3 and FAK expression in VSMC and in neointima was detected by Western blot and immunohistochemistry staining. FAK phosphorylation induced by OPN was verified using a linear OPN 13 peptide containing RGD motif and anti-OPN antibody. The role of integrin beta3-FAK pathway in VSMC adhesion and migration induced with OPN was tested by the overexpression of FAK-related nonkinase and integrin beta3 cytoplasmic domain.
RESULTS: The results showed that OPN increased integrin beta3 expression and induced rapid and transient FAK phosphorylation. Inhibition of the phosphorylation of FAK significantly suppressed VSMC migration induced by OPN. Similarly, blockade of the interaction of integrin beta3 with OPN inhibited VSMC adhesion induced by OPN. The experiment, in vivo, demonstrated that OPN expression level was consistent with neointimal thickening. Administration of anti-OPN antibody for blocking OPN function suppressed integrin beta3 and FAK expression induced by balloon injury, and neointimal thickening was inhibited.
CONCLUSIONS: These data indicate that integrin beta3-FAK signaling modulates OPN-induced VSMC migration during neointimal formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17868879     DOI: 10.1016/j.carpath.2007.04.002

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  12 in total

1.  Integrin β3 mediates cerebrovascular remodelling through Src/ClC-3 volume-regulated Cl(-) channel signalling pathway.

Authors:  Jia-Wei Zeng; Xiao-Guang Wang; Ming-Ming Ma; Xiao-Fei Lv; Jie Liu; Jia-Guo Zhou; Yong-Yuan Guan
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 2.  Osteopontin: an effector and an effect of tumor metastasis.

Authors:  L A Shevde; S Das; D W Clark; R S Samant
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

3.  Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cells.

Authors:  Teresa Cascella; Yashwanth Radhakrishnan; Laura A Maile; Walker H Busby; Katherine Gollahon; Annamaria Colao; David R Clemmons
Journal:  Endocrinology       Date:  2010-09-29       Impact factor: 4.736

4.  Nuclear Focal Adhesion Kinase Controls Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia Through GATA4-Mediated Cyclin D1 Transcription.

Authors:  Kyuho Jeong; Jung-Hyun Kim; James M Murphy; Hyeonsoo Park; Su-Jeong Kim; Yelitza A R Rodriguez; Hyunkyung Kong; Chungsik Choi; Jun-Lin Guan; Joan M Taylor; Thomas M Lincoln; William T Gerthoffer; Jun-Sub Kim; Eun-Young Erin Ahn; David D Schlaepfer; Ssang-Taek Steve Lim
Journal:  Circ Res       Date:  2019-05-17       Impact factor: 17.367

5.  Inhibition of osteopontin reduce the cardiac myofibrosis in dilated cardiomyopathy via focal adhesion kinase mediated signaling pathway.

Authors:  Hui Zhao; Wei Wang; Jie Zhang; Tuo Liang; Guang-Pu Fan; Zhi-Wei Wang; Pei-De Zhang; Xu Wang; Jing Zhang
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

6.  Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway.

Authors:  Guohong Li; Rong Jin; Russell A Norris; Lin Zhang; Shiyong Yu; Fusheng Wu; Roger R Markwald; Anil Nanda; Simon J Conway; Susan S Smyth; D Neil Granger
Journal:  Atherosclerosis       Date:  2009-07-30       Impact factor: 5.162

Review 7.  Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition.

Authors:  Anne George; Arthur Veis
Journal:  Chem Rev       Date:  2008-10-03       Impact factor: 60.622

8.  Activation of RhoA and FAK induces ERK-mediated osteopontin expression in mechanical force-subjected periodontal ligament fibroblasts.

Authors:  So-Yeon Hong; Young-Mi Jeon; Hyun-Jung Lee; Jong-Ghee Kim; Jin-A Baek; Jeong-Chae Lee
Journal:  Mol Cell Biochem       Date:  2009-10-02       Impact factor: 3.396

9.  Aldosterone-induced osteopontin expression in vascular smooth muscle cells involves MR, ERK, and p38 MAPK.

Authors:  Guo-Xiang Fu; Chan-Chan Xu; Yuan Zhong; Ding-Liang Zhu; Ping-Jin Gao
Journal:  Endocrine       Date:  2012-05-16       Impact factor: 3.633

10.  Association between the hypomethylation of osteopontin and integrin β3 promoters and vascular smooth muscle cell phenotype switching in great saphenous varicose veins.

Authors:  Han Jiang; Yu Lun; Xiaoyu Wu; Qian Xia; Xiaoyu Zhang; Shijie Xin; Jian Zhang
Journal:  Int J Mol Sci       Date:  2014-10-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.